GENEVA, SWITZERLAND--(Marketwired - July 14, 2014) - Ares Life Sciences, a healthcare-focused investment group, has today increased its ownership in Esaote SpA, a leading global manufacturer of medical diagnostic imaging systems. With the acquisition of an 8.2% stake for EUR19million, Ares has grown its holding in the Company from 39.8% to 48%.